Stephen Zarrilli Biography and Net Worth

Director of Globus Medical

Stephen T. Zarrilli has served on our Board of Directors since May 2019 and is a member of our Audit Committee. Mr. Zarrilli is the President and Chief Executive Officer of the University City Science Center, an urban research park that provides commercialization resources to life science and technology entrepreneurs.

Mr. Zarrilli has over 25 years of finance, investment and operating experience in technology and life science enterprises. Mr. Zarrilli also has substantial governance experience with public companies. From 2012 to 2018, Mr. Zarrilli served as the President, Chief Executive Officer and Director of Safeguard Scientifics, Inc. a capital provider to technology and life science companies, which he joined in 2007 as Senior Vice President and Chief Financial Officer. He began his career at Deloitte, LLP and was previously the Chairman and Founder of the Penn Valley Group, a management advisory firm; CFO of Fiberlink Communications Corporation, a security software company; CEO of Concellera Software, Inc., a document management software company; and CEO of US Interactive, Inc. a digital marketing firm.

Mr. Zarrilli is a Member of the Risk and Finance Committee of Virtus Investment Partners, Inc., an investment management company. He holds a B.S. in Accounting from LaSalle University and has completed the Advanced Management Program at the Wharton School of the University of Pennsylvania. Mr. Zarrilli’s extensive operating experience, leadership roles, and his financial and accounting expertise qualify him to serve on our board as an audit committee financial expert.

What is Stephen T. Zarrilli's net worth?: The estimated net worth of Stephen T. Zarrilli is at least $391.50 thousand as of August 3rd, 2021. Mr. Zarrilli owns 4,512 shares of Globus Medical stock worth more than $391,502 as of December 13th. This net worth approximation does not reflect any other assets that Mr. Zarrilli may own. Learn More about Stephen T. Zarrilli's net worth.
How do I contact Stephen T. Zarrilli?: The corporate mailing address for Mr. Zarrilli and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on Stephen T. Zarrilli's contact information.
Has Stephen T. Zarrilli been buying or selling shares of Globus Medical?: During the last ninety days, Stephen T. Zarrilli has sold $2,107,250.00 in Globus Medical stock. Most recently, Stephen T. Zarrilli sold 25,000 shares of the business's stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $84.29, for a transaction totalling $2,107,250.00. Learn More on Stephen T. Zarrilli's trading history.
Who are Globus Medical's active insiders?: Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Dan Lemaitre (Director), Leslie Norwalk (Director), Keith Pfeil (CFO), Ann Rhoads (Director), Daniel Scavilla (EVP), James Tobin (Director), and Stephen Zarrilli (Director). Learn More on Globus Medical's active insiders.
Are insiders buying or selling shares of Globus Medical?: During the last year, insiders at the medical device company sold shares 8 times. They sold a total of 110,209 shares worth more than $9,254,434.43. The most recent insider tranaction occured on December, 1st when CFO Kyle Kline sold 18,542 shares worth more than $1,668,780.00. Insiders at Globus Medical own 18.5% of the company. Learn More about insider trades at Globus Medical.
Information on this page was last updated on 12/1/2025.

Stephen T. Zarrilli Insider Trading History at Globus Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/11/2025	Sell	25,000	$84.29	$2,107,250.00

Stephen T. Zarrilli Buying and Selling Activity at Globus Medical

Globus Medical Company Overview

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Today's Range

Now: $86.77

$86.09

$88.87

50 Day Range

MA: $74.46

$56.69

$91.12

2 Week Range

Now: $86.77

$51.79

$94.93

Volume

1,396,088 shs

Average Volume

1,566,002 shs

Market Capitalization

$11.61 billion

P/E Ratio

27.99

Dividend Yield

N/A

Beta

1.07